GeneXpert Technology for the diagnosis of HIV | 合法醫療器材資訊網

由MSaeed著作·2020—GeneXpertistheWHO-endorsedtechnologythatisproventobehighlysensitiveandspecificforthediagnosisofHIV–TBco-infectedpatients.

Synergistic tuberculosis (TB)/human immunodeficiency virus (HIV) co-infections are responsible for epidemics in several nations and have established themselves as a tremendous health challenge to these nations in terms of patient point of care and economic burden on health care organizations [1]. TB is the fundamental driver of HIV-related mortality around the world. Co-infection with these two pathogens results in an accelerated course for the two illnesses and also raises complex challenges in diagnosis and therapy [2]. Around the world, 10% of the general population who developed TB in 2016 were HIV-positive and the vast majority of these were in India, Indonesia, China, Philippines, Pakistan, South Africa and Nigeria [3].

In Eastern Mediterranean regions of the world, Pakistan is ranked the fifth highest TB endemic countries acc...